Published in World J Urol on January 06, 2010
Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia. Korean J Urol (2013) 1.11
Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging (2013) 0.94
A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol (2013) 0.89
Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy. Curr Urol (2013) 0.89
Is it necessary and feasible to increase the efficiency of 2-µm thulium laser resection of the prostate? Asian J Androl (2013) 0.88
Economic Evaluation Study (Cheer Compliant) Laser Prostatectomy for Benign Prostatic Hyperplasia: Outcomes and Cost-effectiveness. Medicine (Baltimore) (2016) 0.86
Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results. Cent European J Urol (2012) 0.86
Efficacy of a vaporization-resection of the prostate median lobe enlargement and vaporization of the prostate lateral lobe for benign prostatic hyperplasia using a 120-W GreenLight high-performance system laser: the effect on storage symptoms. Lasers Med Sci (2015) 0.81
Laser prostatectomy: holmium laser enucleation and photoselective laser vaporization of the prostate. Rev Urol (2013) 0.81
Factors affecting de novo urinary retention after Holmium laser enucleation of the prostate. PLoS One (2014) 0.77
Impact of prostate volume on the efficacy of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate: a retrospective, short-term follow-up study on evaluating feasibility and safety. Yonsei Med J (2010) 0.76
Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction. Ther Adv Urol (2016) 0.75
Durability and complications of photoselective vaporisation of the prostate with the 120W high performance system GreenLight™ lithium triborate laser. Ann R Coll Surg Engl (2014) 0.75
Transurethral 160-W straight beam green laser vaporesection of the prostate: initial experience after 180 procedures. Springerplus (2016) 0.75
The efficacy and safety of 2-μm continuous laser in the treatment of high-risk patients with benign prostatic hyperplasia. Lasers Med Sci (2016) 0.75
Analysis of Thermally Denatured Depth in Laser Vaporization for Benign Prostatic Hyperplasia using a Simulation of Light Propagation and Heat Transfer (secondary publication). Laser Ther (2016) 0.75
Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol (2006) 4.98
Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol (2007) 4.67
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol (2004) 3.72
Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol (2008) 3.37
Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol (2007) 2.93
Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol (2007) 2.61
A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol (2007) 2.53
Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol (2007) 2.46
GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol (2008) 2.33
Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol (2006) 2.11
Holmium laser enucleation of the prostate: results at 6 years. Eur Urol (2007) 2.07
Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol (2006) 1.96
Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol (2007) 1.92
980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol (2007) 1.79
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol (2009) 1.78
Holmium laser enucleation of prostate: outcome and complications of self-taught learning curve. Urology (2009) 1.77
Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int (2007) 1.63
Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology (2004) 1.59
Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol (2006) 1.50
A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol (2001) 1.49
RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol (2007) 1.48
A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol (2006) 1.47
Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol (2008) 1.40
KTP laser versus transurethral resection: early results of a randomized trial. J Endourol (2006) 1.39
Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int (2008) 1.37
Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol (2005) 1.35
Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol (2009) 1.24
Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol (2007) 1.12
The development of laser prostatectomy. BJU Int (2004) 1.10
Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol (2006) 1.10
Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology (1991) 1.08
Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int (2007) 1.08
Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology (2009) 1.06
Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol (2009) 1.04
Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int (2008) 1.04
Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol (2008) 1.04
Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int (2009) 1.03
Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med (1992) 0.96
The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up. Eur Urol (2007) 0.96
Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol (2003) 0.96
Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis (2009) 0.92
Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol (2006) 0.91
Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol (2009) 0.91
Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome. Curr Opin Urol (2009) 0.90
Vaporization of the prostate. Curr Opin Urol (2004) 0.89
Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urol Int (2009) 0.88
Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations. BJU Int (2008) 0.88
Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol (2008) 0.86
Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med (2007) 0.84
Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med (2008) 0.81
Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci (2008) 0.80
From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nat Clin Pract Urol (2005) 0.77
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol (2013) 4.89
Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol (2008) 3.37
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol (2008) 2.33
Laparoscopic living-donor nephrectomy: analysis of the existing literature. Eur Urol (2010) 2.07
Plasma vaporisation of the prostate: initial clinical results. Eur Urol (2009) 1.80
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol (2009) 1.78
Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol (2009) 1.60
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci U S A (2011) 1.59
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease. Endocr Relat Cancer (2013) 1.57
Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol (2006) 1.53
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer. BJU Int (2013) 1.53
High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol (2005) 1.51
Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol (2006) 1.50
Seven hours to adequate antimicrobial therapy in urosepsis using isothermal microcalorimetry. J Clin Microbiol (2013) 1.45
The effect of increased maximum power output on perioperative and early postoperative outcome in photoselective vaporization of the prostate. Lasers Surg Med (2012) 1.41
Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols. Urology (2013) 1.39
Comparison of CT angiography with MR angiography in the preoperative assessment of living kidney donors. Transplantation (2008) 1.39
Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int (2008) 1.37
Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int (2011) 1.25
Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int (2009) 1.21
Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol (2004) 1.18
Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol (2005) 1.12
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Int J Cancer (2009) 1.00
Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol (2011) 0.99
Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clin Cancer Res (2013) 0.99
Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol (2004) 0.98
Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia (2009) 0.98
Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence. Curr Opin Urol (2012) 0.97
The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up. Eur Urol (2007) 0.96
Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors. J Transl Med (2006) 0.95
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. Eur J Cancer (2012) 0.94
Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J Transl Med (2011) 0.94
ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant (2008) 0.94
Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int (2005) 0.93
Laser vaporization of the prostate in vivo: Experience with the 150-W 980-nm diode laser in living canines. Lasers Surg Med (2010) 0.92
Obturator and thigh abscess after transobturator tape implantation for stress urinary incontinence. Urol Int (2008) 0.92
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer. World J Urol (2013) 0.92
Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol (2006) 0.91
Rapid detection of urinary tract pathogens using microcalorimetry: principle, technique and first results. BJU Int (2012) 0.88
Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations. BJU Int (2008) 0.88
Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? Curr Opin Urol (2016) 0.88
ESUT expert group on laparoscopy proposes uniform terminology during radical prostatectomy: we need to speak the same language. Eur Urol (2013) 0.88
Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice. Prostate (2015) 0.87
High-level virtual reality simulator for endourologic procedures of lower urinary tract. Urology (2006) 0.86
Complications of retroperitoneoscopic living donor nephrectomy: single center experience after 164 cases. World J Urol (2008) 0.86
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer. J Pathol (2011) 0.86
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. Eur J Cancer (2008) 0.86
Retroperitoneoscopy-assisted cryoablation of renal tumors using multiple 1.5 mm ultrathin cryoprobes: a preliminary report. Eur Urol (2005) 0.86
Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in comparison with three different techniques. World J Urol (2006) 0.85
The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci (2015) 0.85
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. Prostate (2012) 0.85
Immunotherapy in metastatic renal cell carcinoma. World J Urol (2005) 0.84
Improved detection of microbial ureteral stent colonisation by sonication. World J Urol (2010) 0.84
Virtual reality systems in urologic surgery: an evaluation of the GreenLight simulator. Eur Urol (2013) 0.83
Standardization of isothermal microcalorimetry in urinary tract infection detection by using artificial urine. World J Urol (2012) 0.83
Retroperitoneoscopic management of caliceal diverticular calculi. Urology (2005) 0.83
Laparoscopic adrenalectomy in urological centres - the experience of the German Laparoscopic Working Group. BJU Int (2011) 0.82
Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation. World J Urol (2012) 0.82
Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder. World J Urol (2013) 0.82
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia. J Virol (2012) 0.82
Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer. Urology (2006) 0.82
Ureteral obstruction after dextranomer/hyaluronic acid copolymer injection for treatment of secondary vesicoureteral reflux after renal transplantation. Urology (2006) 0.82
Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci (2008) 0.80
Laparoscopic partial nephrectomy for large renal masses: results of a European survey. World J Urol (2010) 0.79
Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases. Scand J Urol Nephrol (2008) 0.79
Patients' perception of surgical outcomes and quality of life after retroperitoneoscopic and open pyeloplasty. Urol Int (2013) 0.78
Retroperitoneoscopic nephrectomy for autosomal dominant polycystic kidney disease: initial experience. Urol Int (2007) 0.78
Isothermal microcalorimetry accurately detects bacteria, tumorous microtissues, and parasitic worms in a label-free well-plate assay. Biotechnol J (2015) 0.78
ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer. Virchows Arch (2012) 0.78
Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle? World J Urol (2012) 0.77
Therapeutic approaches in metastatic renal cell carcinoma. BJU Int (2005) 0.77
Repeat true surveillance biopsies in kidney transplantation. Transplantation (2012) 0.77